The Traderszone Network

Published in TZ Latest News 8 September, 2017 by The TZ Newswire Staff

A Perfect Storm Cut Teva Pharmaceutical Industries’s Stock in Half in August

Shares of Teva Pharmaceutical Industries (NYSE: TEVA), an Israeli-based developer of branded and generic drugs, imploded in August and lost 51% of its market cap, according to data from S&P Global Market Intelligence. While a perfect storm of issues influenced Teva’s terrible month, most of the blame can be pointed at the company’s second-quarter earnings release.

read more